Literature DB >> 10737766

Retroviral membrane display of apoptotic effector molecules.

D Strehlow1, S Jodo, S T Ju.   

Abstract

Retroviruses have been widely used in gene transmission studies. In this paper, we show that nonviral apoptotic proteins can be displayed on viral membrane surfaces and that the displayed proteins can execute their normal effector functions. We introduced the genes encoding the apoptosis effector proteins, human CD95 ligand (hFasL) or human tumor necrosis factor-related apoptosis-inducing ligand (hTRAIL), into a cell line that packages Moloney murine leukemia virus vectors. Retrovirus preparations from these lines killed target cells efficiently, and target killing was prevented by Fas-Ig fusion protein or soluble TRAIL receptor (sDR5), respectively. We show that the virus preparation exhibiting Fas-specific cytotoxicity has the same density as a retrovirus, contains full-length FasL protein, and can be depleted of infectivity by immunoadsorption with anti-FasL antibody. This novel property of retroviruses-the display of functional effector proteins-may allow the custom design of reagents whose normal function requires their being embedded in a membrane.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10737766      PMCID: PMC18199          DOI: 10.1073/pnas.070049197

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Use of retroviral vectors for gene transfer and expression.

Authors:  A D Miller; D G Miller; J V Garcia; C M Lynch
Journal:  Methods Enzymol       Date:  1993       Impact factor: 1.600

2.  Retroviral vector particles displaying the antigen-binding site of an antibody enable cell-type-specific gene transfer.

Authors:  T H Chu; R Dornburg
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

3.  Tissue-specific targeting of retroviral vectors through ligand-receptor interactions.

Authors:  N Kasahara; A M Dozy; Y W Kan
Journal:  Science       Date:  1994-11-25       Impact factor: 47.728

4.  Evidence for type-C retrovirus production by Burkitt's lymphoma-derived cell line.

Authors:  A Yaniv; T Gotlieb-Stematsky; A Vonsover; K Perk
Journal:  Int J Cancer       Date:  1980-02-15       Impact factor: 7.396

5.  Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors.

Authors:  S Valsesia-Wittmann; A Drynda; G Deléage; M Aumailley; J M Heard; O Danos; G Verdier; F L Cosset
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  Chronically HIV-1-infected monocytic cells induce apoptosis in cocultured T cells.

Authors:  H Chen; Y K Yip; I George; M Tyorkin; E Salik; K Sperber
Journal:  J Immunol       Date:  1998-10-15       Impact factor: 5.422

7.  Human Fas ligand: gene structure, chromosomal location and species specificity.

Authors:  T Takahashi; M Tanaka; J Inazawa; T Abe; T Suda; S Nagata
Journal:  Int Immunol       Date:  1994-10       Impact factor: 4.823

8.  Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120.

Authors:  M O Westendorp; R Frank; C Ochsenbauer; K Stricker; J Dhein; H Walczak; K M Debatin; P H Krammer
Journal:  Nature       Date:  1995-06-08       Impact factor: 49.962

9.  Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation.

Authors:  S T Ju; D J Panka; H Cui; R Ettinger; M el-Khatib; D H Sherr; B Z Stanger; A Marshak-Rothstein
Journal:  Nature       Date:  1995-02-02       Impact factor: 49.962

10.  Expression of the functional soluble form of human fas ligand in activated lymphocytes.

Authors:  M Tanaka; T Suda; T Takahashi; S Nagata
Journal:  EMBO J       Date:  1995-03-15       Impact factor: 11.598

View more
  1 in total

1.  The Trojan exosome hypothesis.

Authors:  Stephen J Gould; Amy M Booth; James E K Hildreth
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-28       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.